Blocking c-Met signaling enhances bone morphogenetic protein-2-induced osteoblast differentiation.
Blocking c-Met signaling enhances bone morphogenetic protein-2-induced osteoblast differentiation.
复制标题
阻断 c-Met 信号传导可增强骨形态发生蛋白 2 诱导的成骨细胞分化。
DOI:
10.1016/j.fob.2015.04.008
复制
发表时间:
2015
期刊:
影响因子:
2.6
通讯作者:
Iwasaki, Tsuyoshi
中科院分区:
文献类型:
--
作者:
Shibasaki, Seiji;Kitano, Sachie;Karasaki, Miki;Tsunemi, Sachi;Sano, Hajime;Iwasaki, Tsuyoshi
Role of c-Met signaling in osteoblast differentiation was investigated. Osteoblast differentiation was determined by ALP and osteocalcin production by C2C12 and MC3T3-E1 cells. c-Met signaling negatively regulates osteoblast differentiation. Blocking c-Met signaling might serve as a therapeutic strategy for rheumatoid arthritis. We previously demonstrated that blocking hepatocyte growth factor (HGF) receptor/c-Met signaling inhibited arthritis and articular bone destruction in mouse models of rheumatoid arthritis (RA). In the present study, we investigated the role of c-Met signaling in osteoblast differentiation using the C2C12 myoblast cell line derived from murine satellite cells and the MC3T3-E1 murine pre-osteoblast cell line. Osteoblast differentiation was induced by treatment with bone morphogenetic protein (BMP)-2 or osteoblast-inducer reagent in the presence or absence of either HGF antagonist (NK4) or c-Met inhibitor (SU11274). Osteoblast differentiation was confirmed by Runx2 expression, and alkaline phosphatase (ALP) and osteocalcin production by the cells. Production of ALP, osteocalcin and HGF was verified by enzyme-linked immunosorbent assay. Runx2 expression was confirmed by reverse transcription-PCR analysis. The phosphorylation status of ERK1/2, AKT, and Smads was determined by Western blot analysis. Both NK4 and SU11274 enhanced Runx2 expression, and ALP and osteocalcin production but suppressed HGF production in BMP-2-stimulated C2C12 cells. SU11274 also enhanced ALP and osteocalcin production in osteoblast-inducer reagent-stimulated MC3T3-E1 cells. SU11274 inhibited ERK1/2 and AKT phosphorylation in HGF-stimulated C2C12 cells. This result suggested that ERK and AKT were functional downstream of the c-Met signaling pathway. However, both mitogen-activated protein kinase/ERK kinase (MEK) and phosphatidylinositol 3-kinase (PI3K) inhibitor suppressed osteocalcin and HGF production in BMP-2-stimulated C2C12 cells. Furthermore, SU11274, MEK, and PI3K inhibitor suppressed Smad phosphorylation in BMP-2-stimulated C2C12 cells. These results indicate that although the c-Met-MEK-ERK-Smad and c-Met-PI3K-AKT-Smad signaling pathways positively regulate osteoblast differentiation, c-Met signaling negatively regulates osteoblast differentiation, independent of the MEK-ERK-Smad and PI3K-AKT-Smad pathways. Therefore, blocking c-Met signaling might serve as a therapeutic strategy for the repair of destructed bone in patients with RA.
登录
查看更多内容
影响因子:
4.1
作者:
Chen, Ketian;Perez-Stable, Carlos;Howard, Guy A.
通讯作者:
Howard, Guy A.
影响因子:
--
作者:
Kitano, M;Hla, T;Sano, H
通讯作者:
Sano, H
影响因子:
19.6
作者:
Ducy, P;Karsenty, G
通讯作者:
Karsenty, G
影响因子:
14
作者:
Kawaski, Toshiki;Niki, Yasuo;Toyama, Yoshiaki
通讯作者:
Toyama, Yoshiaki
影响因子:
3.7
作者:
Nakamura, K;Shirai, T;Makishima, F
通讯作者:
Makishima, F